BILH-434

CAS No. 760169-28-6

BILH-434( BILH434 )

Catalog No. M15887 CAS No. 760169-28-6

BILH-434 is a potent HPV11 E1/E2/DNA complex inhibitor that binds to the transactivation domain (TAD) of E2 protein with a Kd of 40 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    BILH-434
  • Note
    Research use only, not for human use.
  • Brief Description
    BILH-434 is a potent HPV11 E1/E2/DNA complex inhibitor that binds to the transactivation domain (TAD) of E2 protein with a Kd of 40 nM.
  • Description
    BILH-434 is a potent HPV11 E1/E2/DNA complex inhibitor that binds to the transactivation domain (TAD) of E2 protein with a Kd of 40 nM, has an IC50 of 180 nM in the E1-E2-ori complex formation assay.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    BILH434
  • Pathway
    Microbiology/Virology
  • Target
    HPV
  • Recptor
    HPV
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    760169-28-6
  • Formula Weight
    608.446
  • Molecular Formula
    C29H19Cl2N3O6S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    (2R,3'R,4'S,5'R)-5'-(3,4-dichlorophenyl)-5-methyl-1,3-dioxo-4'-[[4-(thiadiazol-4-yl)phenyl]carbamoyl]spiro[indene-2,2'-oxolane]-3'-carboxylic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Arkin MR, et al. Chem Biol. 2014 Sep 18;21(9):1102-14. 2. Wang Y, et al. J Biol Chem. 2004 Feb 20;279(8):6976-85.
molnova catalog
related products
  • Human Papillomavirus...

    Human Papillomavirus (HPV) E7 protein (49-57) is the H-2d-restricted human papillomavirus (HPV) E749-57 epitope.

  • BILH-434

    BILH-434 is a potent HPV11 E1/E2/DNA complex inhibitor that binds to the transactivation domain (TAD) of E2 protein with a Kd of 40 nM.

  • Teslexivir

    A first-in-class, small molecule protein-protein inhibitor of the interaction between the E1 and E2 proteins of HPV types 6 and 11.